Regeneron Says Large-Scale Human Genetics Starting to Generate New Drug Targets

Nov 16, 2017

|

Premium

NEW YORK (GenomeWeb) – Three years after Regeneron Pharmaceuticals began sequencing human exomes on a large scale and analyzing them along with electronic health records, the effort has started to bear fruit in the form of new drug targets and additional insights into existing ones.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

John Mendelsohn Dies

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

The Preliminary Investigation

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

Similar, But Not Quite the Same

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

This Week in PNAS

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.

Featured White Papers

KAPA HyperPrep Kits offer a flexible, high-efficiency library preparation solution for PCR-free human whole-genome sequencing

Controlling Ribonuclease (RNase) with High Irradiance UV LED Light Engines

DNA Quantification and Normalization with Promega QuantiFluor Dyes on the Fluent Laboratory Automation Solution

Nucleic Acid Quantification and Normalization by UV Measurement on the Fluent Laboratory Automation Solution

Jan

30

Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan

31

Featured Webinar

Leveraging Single-Cell Genomics to Identify Drivers of Enhanced Immunity

This webinar highlights the use of single-cell genomics to identify distinct cell types and states associated with enhanced immunity.

Feb

14

Featured Webinar

Transcriptome of an Agricultural Pest Delineated by Oxford Nanopore RNA-Seq

This webinar will describe a project that applied Oxford Nanopore long-read RNA-seq to explore the transcriptional landscape of a damaging agricultural pest.

Feb

19

Featured Webinar

Rapid Testing of Solid Tumor Samples Using a Single-Vial NGS Assay

This webinar will demonstrate how clinical laboratories can develop their own customized targeted next-generation sequencing (NGS)-based solid tumor panels.

Main menu